DFI Continues Global Growth with Patented CVD Industrial Nanocoating System

Diamon-Fusion International, Inc. (DFI Nanotechnology), global developer and exclusive licensor of patented hydrophobic nanotechnologies, announced today the signing of a new license agreement in Spain with CRISTEC VIPLA, a highly reputable Catalunya-based company. This agreement provides a significant increase in DFI's market penetration in Architectural markets Spain wide.

CRISTEC VIPLA, a 20- year privately-owned company based in Lleida (near Barcelona) and an ISO-9001 certified company, is dedicated to the fabrication and processing of a wide range of glass product reaching a diversity of market segments, including aluminum, PVC, furniture, and other industries. Cristec also manufactures dual-glazed units (insulated glass), laminated, and tempered glass - see projects' photographs on the right and below - and bullet-resistant glass. Cristec is fully certified in all its manufacturing processes.

"DFI's patented nanocoating offers a unique added-value as a surface protection barrier that will enhance a wide range of our products; we need to remain innovative and offer the best value to our customers, which is the main objective in signing this agreement with DFI ", said Jose Planes, Managing Director of CRISTEC VIPLA.

"We are pleased to have reached this agreement with such well-established and greatly respected company in Spain's glass industry; we are looking forward to a long and mutually rewarding relationship", commented Francisco Bono, Business Director of Aries, DFI's exclusive representative in Spain.

Guillermo Seta, Executive Director of DFI Global Operations, explained, "This agreement with Cristec Vipla provides an additional large-scale partner in the EU to continue our growth in a wide range of markets and to solidify our Diamon-Fusion flagship nanocoating as the premier surface protection system across many market segments."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.